Skip to content
  • 6,813 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Combined synopsis and solicitation

Primary Human Trophoblast Cells

75F40126Q134903

Food and Drug Administration, FDA Office of Acq Grant SVCS. In-Vitro Diagnostic Substance Manufacturing.

13 open like this View on SAM.gov Markdown

Response deadline

August 31, 2026 at 2:00 PM EDT

Closed 62 days ago. Posted August 26, 2026. Scheduled to archive September 15, 2026.

Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities

This one closed in 2026

13 like it are open now in in-vitro diagnostic substance manufacturing

All 13 open in in-vitro diagnostic substance manufacturing

Description

As published on SAM.gov.

See Attached Combined Synopsis/Solicitation 75F40126Q134903

Attachments

Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 26, 2026

    Combined synopsis and solicitation

    Due August 31, 2026 at 2:00 PM EDT. SAM.gov, notice 8a0e5a3d6eee4a03870e5aa3275f06f3

    1 revisions on SAM
    • August 26, 2026: publish, combined synopsis and solicitation

Points of contact